Modern intravenous iron compounds (e.g., ferric carboxymaltose (FCM) and ferric derisomaltose (FDI)) are utilized in the treatment of iron deficiency anemia in non-dialysis dependent chronic kidney di
Legend: Unadjusted and adjusted hazard ratios (HR) and 95% Confidence Intervals (CI) for end-stage renal disease (ESRD) and death associated with 1 unit (µmol/L) change in homoarginine. (‡) Relative r
ABSTRACT Glomerular proteinuria is characterized by the loss of high-molecular-weight proteins (HMWPs), while tubulointerstitial proteinuria is characterized by the loss of low-molecular-weight protei
